This statistic shows the loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020. In 2011, there was a total loss in exclusivity of 16 billion U.S. dollars among small molecule products in developed markets. Patent expiries reached a peak in 2012 when Lipitor, Plavix, Singulari, and Seroquel experienced competition from generics in the United States.
Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health (Institute for Healthcare Informatics). (November 25, 2015). Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/
IMS Health (Institute for Healthcare Informatics). "Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)." Chart. November 25, 2015. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/
IMS Health (Institute for Healthcare Informatics). (2015). Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/
IMS Health (Institute for Healthcare Informatics). "Loss through Small Molecule Patent Expiries in Developed Pharmaceutical Markets from 2011 to 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 25 Nov 2015, https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/
IMS Health (Institute for Healthcare Informatics), Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/ (last visited December 21, 2024)
Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars) [Graph], IMS Health (Institute for Healthcare Informatics), November 25, 2015. [Online]. Available: https://www.statista.com/statistics/373885/value-of-small-molecule-products-facing-patent-expiries-worldwide/
